ST. AUGUSTINE, FL, Kihealth, a precision diagnostics company pioneering early disease detection, announced today the close of its $5 million seed round.
The round was oversubscribed, reflecting strong investor confidence in the company's breakthrough approach to metabolic health and disease prevention.
Kihealth is a life sciences company focused on research, development and commercialization of novel diagnostics, products and services for the treatment of metabolic disease, gut health and auto-immune disorders. Their initial diagnostic will offer the earliest detection of pre-diabetes on the market
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
